Cite
HARVARD Citation
Komeda, T. et al. (n.d.). Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors. Journal of infection and chemotherapy. 22 (10), pp. 677-684. [Online].